Trials / Unknown
UnknownNCT02209415
EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer
Endoscopic Ultrasound (EUS) and PET-CT Based Follow-up of Patients Radically Resected for Cancer of the Oesophagus, Stomach or Pancreas.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 182 (estimated)
- Sponsor
- Michael Bau Mortensen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Follow-up after successful operative treatment of cancer in the esophagus, stomach or pancreas in order to detect recurrent disease is a controversial topic. This is because the methods and the consequence of following these patients is unknown. Therefore the investigators will randomize these patients in to two groups: 1. One group of patients will be offered visits with a specialist surgeon in a outpatient setting for a clinical evaluation every 3,6,9,12,18 and 24 months after surgery, as is the current standard at our department. 2. The other group will be offered Endoscopic UltraSound, EUS, and PET/CT with the same intervals as the first group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | standard follow-up | Outpatient clinic visits |
| PROCEDURE | PET/CT and EUS | PET/CT and EUS |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2016-01-01
- Completion
- 2016-08-01
- First posted
- 2014-08-05
- Last updated
- 2014-08-05
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02209415. Inclusion in this directory is not an endorsement.